ELCRX
Price
$44.52
Change
-$0.14 (-0.31%)
Updated
Dec 3 closing price
Net Assets
463.96M
FFAFX
Price
$89.36
Change
+$0.53 (+0.60%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

ELCRX vs FFAFX

Header iconELCRX vs FFAFX Comparison
Open Charts ELCRX vs FFAFXBanner chart's image
Eaton Vance Growth R
Price$44.52
Change-$0.14 (-0.31%)
VolumeN/A
Net Assets463.96M
American Funds Growth Fund of Amer 529F3
Price$89.36
Change+$0.53 (+0.60%)
VolumeN/A
Net Assets338.91B
ELCRX vs FFAFX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFAFX has more cash in the bank: 339B vs. ELCRX (464M). FFAFX pays higher dividends than ELCRX: FFAFX (0.54) vs ELCRX (0.00). ELCRX was incepted earlier than FFAFX: ELCRX (16 years) vs FFAFX (5 years). ELCRX (1.28) is less costly to investors than FFAFX (0.35). FFAFX is a more actively managed with annual turnover of: 25.00 vs. ELCRX (18.00). FFAFX has a lower initial minimum investment than ELCRX: FFAFX (250) vs ELCRX (1000). FFAFX annual gain was more profitable for investors over the last year : 7.34 vs. ELCRX (6.30). FFAFX return over 5 years is better than : 34.69 vs. ELCRX (25.25).
ELCRXFFAFXELCRX / FFAFX
Total Expense Ratio1.280.35366%
Annual Report Gross Expense Ratio1.280.35366%
Fund Existence16 years5 years-
Gain YTD14.73519.20577%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets464M339B0%
Annual Yield % from dividends0.000.54-
Returns for 1 year6.307.3486%
Returns for 3 years56.1263.7188%
Returns for 5 years25.2534.6973%
Returns for 10 years96.82N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SEPW31.700.06
+0.19%
AllianzIM U.S. Large Cp Buffer20 Sep ETF
VNIE24.20N/A
N/A
Vontobel International Equity Active ETF
JBBB47.71-0.01
-0.02%
Janus Henderson B-BBB CLO ETF
PSQO20.78-0.03
-0.12%
Palmer Square Credit Opportunities ETF
IBBQ28.22-0.17
-0.59%
Invesco Nasdaq Biotechnology ETF